Lyka Labs Limited (BOM:500259)
63.72
+3.45 (5.72%)
At close: Jun 5, 2026
Lyka Labs Revenue
In the fiscal year ending March 31, 2026, Lyka Labs had annual revenue of 1.28B INR, down -4.78%. Lyka Labs had revenue of 280.31M in the quarter ending March 31, 2026, a decrease of -6.04%.
Revenue
1.28B
Revenue Growth
-4.78%
P/S Ratio
1.77
Revenue / Employee
2.57M
Employees
499
Market Cap
2.27B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Mar 31, 2026 | 1.28B | -64.55M | -4.78% |
| Mar 31, 2025 | 1.35B | 287.16M | 27.04% |
| Mar 31, 2024 | 1.06B | 167.66M | 18.75% |
| Mar 31, 2023 | 894.17M | -950.50M | -51.53% |
| Mar 31, 2022 | 1.84B | 1.16B | 169.25% |
| Mar 31, 2021 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Mar 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Ambalal Sarabhai Enterprises | 2.02B |
| Sat Kartar Life | 2.01B |
| Everest Organics | 1.97B |
| Gennex Laboratories | 1.81B |
| Kerala Ayurveda | 1.31B |
| Astonea Labs | 1.17B |
| Oxygenta Pharmaceutical | 1.13B |
| BDH Industries | 959.55M |
Lyka Labs News
- 11 months ago - Lyka Labs shares fall 3% as Q1 net profit falls 20% YoY; Check earnings - Business Upturn
- 1 year ago - Lyka Labs secures patent for Pregabalin Gel 8% to treat diabetic neuropathic pain - Business Upturn